Gebelac is a medical reference app for iOS that allows healthcare professionals and mothers to query the pregnancy and lactation risk status of medications.
The App DNA
What makes this app unique?
Users hire Gebelac to quickly verify drug safety during pregnancy and breastfeeding, reducing the time required to consult clinical reference materials.
For Healthcare professionals including doctors, pharmacists, and nurses, as well as expectant and nursing mothers seeking safety information on medications.
What does it look like?
Key features
Database lookup for drug active ingredients and herbal products to determine pregnancy risk categories.
Database lookup for drug active ingredients and herbal products to determine safety during breastfeeding.
How much does it cost?
The app operates as a free, ad-free utility with no visible monetization or subscription gates.
Velocity
Dormant developmentopaqueShow more...
The app has not received a public update in over 1,200 days, placing it firmly in the zombie category. The last recorded release was a rebranding effort that transitioned the app to its current name. There is no evidence of ongoing development, feature expansion, or maintenance activity since early 2023.
Who built it?
Adem Emre Celik
3 apps tracked · Medical
DoktorBUN: Hekim Uygulaması
Vizite: Reçete-Order AsistanıUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Gebelac: Güvenli Anne & Bebek
How's the Medical market?
Gebelac functions as a niche medical utility with no active chart presence, relying on its specialized database to serve a professional and patient audience. The 1,200-day update gap positions it as a legacy tool rather than a modern clinical resource.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Gebelac: Güvenli Anne & Bebek
Where is it heading?
The medical reference market is consolidating around tools that offer real-time data updates and integration with clinical workflows. Gebelac remains exposed due to its stagnant update cadence, which will likely lead to user attrition as professionals migrate to more current, frequently updated alternatives.
- The 1,200-day update gap suggests the app is in maintenance mode, which reduces its utility as a reliable clinical reference tool.
The SWOT
- Specialized medical database provides immediate risk categorization for pregnancy and lactation.
- Free, ad-free model removes barriers to adoption for clinical staff.
- Partnerships with medical associations could establish the app as a standard reference tool.
Next best moves
Audit database currency because the app has been silent for 40 months → restore professional trust
The counter-intuitive read
The app's lack of monetization is not a…
Read the full takeSince the last report: The analysis of Gebelac has shifted to reflect its status as a legacy tool, emphasizing the risks posed by its 1,200-day update gap and the resulting competitive disadvantage against frequently updated alternatives.
Bottom line
Gebelac provides a valuable, focused utility for pregnancy safety, but the 3-year update gap erodes trust among medical professionals, so the developer must commit to a quarterly data-refresh cycle to remain a viable clinical resource.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated